|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 1282 for Tlr9

0.039s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Lalanne AI
Year: 2010
Journal: J Immunol
Title: CpG inhibits pro-B cell expansion through a cathepsin B-dependent mechanism.
Volume: 184
Issue: 10
Pages: 5678-85
Publication
First Author: Uematsu S
Year: 2005
Journal: J Exp Med
Title: Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Volume: 201
Issue: 6
Pages: 915-23
Publication
First Author: Akkaya M
Year: 2018
Journal: Nat Immunol
Title: Toll-like receptor 9 antagonizes antibody affinity maturation.
Volume: 19
Issue: 3
Pages: 255-266
Publication
First Author: Chu T
Year: 2019
Journal: J Immunol
Title: Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.
Volume: 202
Issue: 9
Pages: 2529-2534
Publication
First Author: Landrigan A
Year: 2011
Journal: J Immunol
Title: CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism.
Volume: 187
Issue: 6
Pages: 3033-43
Publication
First Author: Krug A
Year: 2004
Journal: Blood
Title: Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.
Volume: 103
Issue: 4
Pages: 1433-7
Publication
First Author: Ehlers M
Year: 2006
Journal: J Exp Med
Title: TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
Volume: 203
Issue: 3
Pages: 553-61
Publication
First Author: Shinohara ML
Year: 2006
Journal: Nat Immunol
Title: Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.
Volume: 7
Issue: 5
Pages: 498-506
Publication  
First Author: Fukui R
Year: 2018
Journal: Front Immunol
Title: Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA.
Volume: 9
Pages: 1491
Publication  
First Author: Wen M
Year: 2015
Journal: Nat Commun
Title: Stk38 protein kinase preferentially inhibits TLR9-activated inflammatory responses by promoting MEKK2 ubiquitination in macrophages.
Volume: 6
Pages: 7167
Publication
First Author: Yu P
Year: 2006
Journal: Int Immunol
Title: Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Volume: 18
Issue: 8
Pages: 1211-9
Publication  
First Author: Ford SL
Year: 2023
Journal: Int J Mol Sci
Title: Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis.
Volume: 24
Issue: 2
Publication
First Author: Wu Y
Year: 2011
Journal: J Immunol
Title: CMRF-35-like molecule 3 preferentially promotes TLR9-triggered proinflammatory cytokine production in macrophages by enhancing TNF receptor-associated factor 6 ubiquitination.
Volume: 187
Issue: 9
Pages: 4881-9
Publication
First Author: Ohto U
Year: 2015
Journal: Nature
Title: Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.
Volume: 520
Issue: 7549
Pages: 702-5
Publication
First Author: Weinkopff T
Year: 2013
Journal: Infect Immun
Title: Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.
Volume: 81
Issue: 5
Pages: 1575-84
Publication
First Author: Omiya S
Year: 2016
Journal: Am J Physiol Heart Circ Physiol
Title: Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation.
Volume: 311
Issue: 6
Pages: H1485-H1497
Publication
First Author: Ramirez-Ortiz ZG
Year: 2008
Journal: Infect Immun
Title: Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA.
Volume: 76
Issue: 5
Pages: 2123-9
Publication
First Author: Lai JCY
Year: 2019
Journal: J Immunol
Title: Topical Adjuvant Application during Subcutaneous Vaccination Promotes Resident Memory T Cell Generation.
Volume: 203
Issue: 9
Pages: 2443-2450
Publication
First Author: Lindau D
Year: 2013
Journal: Eur J Immunol
Title: Primary blood neutrophils express a functional cell surface Toll-like receptor 9.
Volume: 43
Issue: 8
Pages: 2101-13
Publication
First Author: McGlasson SL
Year: 2017
Journal: Eur J Immunol
Title: Human β-defensin 3 increases the TLR9-dependent response to bacterial DNA.
Volume: 47
Issue: 4
Pages: 658-664
Publication
First Author: Summers SA
Year: 2010
Journal: Am J Pathol
Title: Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis.
Volume: 177
Issue: 5
Pages: 2234-44
Publication
First Author: Abu-Tair L
Year: 2013
Journal: PLoS One
Title: Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.
Volume: 8
Issue: 12
Pages: e82571
Publication
First Author: Yasuda H
Year: 2008
Journal: Am J Physiol Renal Physiol
Title: Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury.
Volume: 294
Issue: 5
Pages: F1050-8
Publication  
First Author: Patel V
Year: 2016
Journal: Neuroscience
Title: Synaptic abnormalities of mice lacking toll-like receptor (TLR)-9.
Volume: 324
Pages: 1-10
Publication
First Author: da Silva-Junior EB
Year: 2021
Journal: Sci Rep
Title: The role of Toll-like receptor 9 in a murine model of Cryptococcus gattii infection.
Volume: 11
Issue: 1
Pages: 1407
Publication
First Author: Benmohamed F
Year: 2014
Journal: PLoS One
Title: Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection.
Volume: 9
Issue: 3
Pages: e90466
Publication
First Author: Fischer A
Year: 2018
Journal: J Cell Mol Med
Title: The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis.
Volume: 22
Issue: 9
Pages: 4399-4409
Publication
First Author: Faust SM
Year: 2013
Journal: J Clin Invest
Title: CpG-depleted adeno-associated virus vectors evade immune detection.
Volume: 123
Issue: 7
Pages: 2994-3001
Publication
First Author: Plitas G
Year: 2008
Journal: J Exp Med
Title: Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis.
Volume: 205
Issue: 6
Pages: 1277-83
Publication
First Author: Tsuji N
Year: 2016
Journal: J Am Soc Nephrol
Title: Role of Mitochondrial DNA in Septic AKI via Toll-Like Receptor 9.
Volume: 27
Issue: 7
Pages: 2009-20
Publication  
First Author: Lohner R
Year: 2013
Journal: Mediators Inflamm
Title: Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis.
Volume: 2013
Pages: 261049
Publication
First Author: Uchiyama S
Year: 2012
Journal: PLoS Pathog
Title: DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognition.
Volume: 8
Issue: 6
Pages: e1002736
Publication
First Author: Amcheslavsky A
Year: 2005
Journal: J Bone Miner Res
Title: Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Volume: 20
Issue: 9
Pages: 1692-9
Publication
First Author: Rodrigues FL
Year: 2015
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Toll-like receptor 9 plays a key role in the autonomic cardiac and baroreflex control of arterial pressure.
Volume: 308
Issue: 8
Pages: R714-23
Publication
First Author: Hochrein H
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.
Volume: 101
Issue: 31
Pages: 11416-21
Publication
First Author: Ivory CP
Year: 2008
Journal: Infect Immun
Title: Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA.
Volume: 76
Issue: 1
Pages: 289-97
Publication
First Author: Haas T
Year: 2008
Journal: Immunity
Title: The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Volume: 28
Issue: 3
Pages: 315-23
Publication
First Author: Yasuda K
Year: 2009
Journal: J Immunol
Title: Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.
Volume: 183
Issue: 5
Pages: 3109-17
Publication
First Author: Chockalingam A
Year: 2011
Journal: Eur J Immunol
Title: Negative regulation of signaling by a soluble form of toll-like receptor 9.
Volume: 41
Issue: 8
Pages: 2176-84
Publication
First Author: Pau E
Year: 2012
Journal: PLoS One
Title: TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.
Volume: 7
Issue: 5
Pages: e36761
Publication  
First Author: David BT
Year: 2013
Journal: Neurobiol Dis
Title: A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury.
Volume: 54
Pages: 194-205
Publication
First Author: Good M
Year: 2014
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.
Volume: 306
Issue: 11
Pages: G1021-32
Publication
First Author: Sekheri M
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: 15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation.
Volume: 117
Issue: 14
Pages: 7971-7980
Publication
First Author: Ivanov S
Year: 2007
Journal: Blood
Title: A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
Volume: 110
Issue: 6
Pages: 1970-81
Publication
First Author: Sarangi PP
Year: 2007
Journal: J Virol
Title: Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis.
Volume: 81
Issue: 20
Pages: 11128-38
Publication
First Author: Wang JQ
Year: 2014
Journal: J Exp Med
Title: Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance.
Volume: 211
Issue: 3
Pages: 413-26
Publication
First Author: Herlands RA
Year: 2008
Journal: Immunity
Title: T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
Volume: 29
Issue: 2
Pages: 249-60
Publication
First Author: Tyznik AJ
Year: 2008
Journal: J Immunol
Title: Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.
Volume: 181
Issue: 7
Pages: 4452-6
Publication  
First Author: Chan MP
Year: 2015
Journal: Nat Commun
Title: DNase II-dependent DNA digestion is required for DNA sensing by TLR9.
Volume: 6
Pages: 5853
Publication
First Author: Xiao N
Year: 2009
Journal: J Immunol
Title: The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease.
Volume: 183
Issue: 12
Pages: 7975-83
Publication
First Author: Burt BM
Year: 2008
Journal: J Leukoc Biol
Title: CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis.
Volume: 84
Issue: 4
Pages: 1039-46
Publication
First Author: Kubo T
Year: 2009
Journal: J Exp Med
Title: Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.
Volume: 206
Issue: 9
Pages: 1971-82
Publication
First Author: Sasai M
Year: 2010
Journal: Science
Title: Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3.
Volume: 329
Issue: 5998
Pages: 1530-4
Publication
First Author: Qi J
Year: 2011
Journal: J Immunol
Title: Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.
Volume: 186
Issue: 11
Pages: 6417-26
Publication
First Author: Hasan M
Year: 2008
Journal: Immunology
Title: Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.
Volume: 123
Issue: 2
Pages: 239-49
Publication
First Author: Karper JC
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.
Volume: 32
Issue: 8
Pages: e72-80
Publication
First Author: Naito Y
Year: 2020
Journal: Am J Physiol Renal Physiol
Title: IL-17A activated by Toll-like receptor 9 contributes to the development of septic acute kidney injury.
Volume: 318
Issue: 1
Pages: F238-F247
Publication
First Author: Han SJ
Year: 2019
Journal: Kidney Int
Title: Intestinal Toll-like receptor 9 deficiency leads to Paneth cell hyperplasia and exacerbates kidney, intestine, and liver injury after ischemia/reperfusion injury.
Volume: 95
Issue: 4
Pages: 859-879
Publication
First Author: Kotaki R
Year: 2015
Journal: Immunobiology
Title: Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells.
Volume: 220
Issue: 6
Pages: 734-43
Publication
First Author: Wang JP
Year: 2012
Journal: J Virol
Title: Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.
Volume: 86
Issue: 4
Pages: 2273-81
Publication
First Author: Sjölinder H
Year: 2008
Journal: Infect Immun
Title: Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.
Volume: 76
Issue: 11
Pages: 5421-8
Publication
First Author: Thurlow LR
Year: 2011
Journal: J Immunol
Title: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.
Volume: 186
Issue: 11
Pages: 6585-96
Publication
First Author: Moseman AP
Year: 2013
Journal: J Immunol
Title: Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
Volume: 191
Issue: 11
Pages: 5615-24
Publication
First Author: Foureau DM
Year: 2010
Journal: J Immunol
Title: TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii.
Volume: 184
Issue: 12
Pages: 7022-9
Publication
First Author: He L
Year: 2011
Journal: PLoS One
Title: Toll-like receptor 9 is required for opioid-induced microglia apoptosis.
Volume: 6
Issue: 4
Pages: e18190
Publication
First Author: Gray RC
Year: 2007
Journal: J Leukoc Biol
Title: CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
Volume: 81
Issue: 4
Pages: 1075-85
Publication
First Author: Traub S
Year: 2012
Journal: PLoS One
Title: Sex bias in susceptibility to MCMV infection: implication of TLR9.
Volume: 7
Issue: 9
Pages: e45171
Publication
First Author: Alikhan MA
Year: 2016
Journal: J Am Soc Nephrol
Title: Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment.
Volume: 27
Issue: 3
Pages: 706-14
Publication  
First Author: Khariv V
Year: 2013
Journal: Brain Behav Immun
Title: Toll-like receptor 9 deficiency impacts sensory and motor behaviors.
Volume: 32
Pages: 164-72
Publication
First Author: Ramaprakash H
Year: 2009
Journal: Infect Immun
Title: Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice.
Volume: 77
Issue: 1
Pages: 108-19
Publication
First Author: Ito T
Year: 2009
Journal: Am J Respir Crit Care Med
Title: Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation.
Volume: 180
Issue: 12
Pages: 1227-38
Publication
First Author: Ishii M
Year: 2008
Journal: Eur J Immunol
Title: CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.
Volume: 38
Issue: 8
Pages: 2290-302
Publication
First Author: Carvalho LP
Year: 2012
Journal: J Immunol
Title: Lymph node hypertrophy following Leishmania major infection is dependent on TLR9.
Volume: 188
Issue: 3
Pages: 1394-401
Publication
First Author: Barrat FJ
Year: 2005
Journal: J Exp Med
Title: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
Volume: 202
Issue: 8
Pages: 1131-9
Publication
First Author: Richard K
Year: 2008
Journal: J Immunol
Title: The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo.
Volume: 181
Issue: 3
Pages: 1746-52
Publication
First Author: Huang Y
Year: 2020
Journal: J Neurosci
Title: Synergistic Toll-like Receptor 3/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia.
Volume: 40
Issue: 33
Pages: 6428-6443
Publication
First Author: Daly K
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Toll-like receptor 9 expressed in proximal intestinal enteroendocrine cells detects bacteria resulting in secretion of cholecystokinin.
Volume: 525
Issue: 4
Pages: 936-940
Publication
First Author: Chen X
Year: 2020
Journal: Gastroenterology
Title: Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
Volume: 159
Issue: 6
Pages: 2181-2192.e1
Publication
First Author: Liu M
Year: 2018
Journal: Diabetologia
Title: Toll-like receptor 9 negatively regulates pancreatic islet beta cell growth and function in a mouse model of type 1 diabetes.
Volume: 61
Issue: 11
Pages: 2333-2343
Publication
First Author: Chen L
Year: 2010
Journal: PLoS One
Title: Critical role of toll-like receptor 9 in morphine and Mycobacterium tuberculosis-Induced apoptosis in mice.
Volume: 5
Issue: 2
Pages: e9205
Publication
First Author: Xiang Y
Year: 2015
Journal: PLoS One
Title: The role of toll-like receptor 9 in chronic stress-induced apoptosis in macrophage.
Volume: 10
Issue: 4
Pages: e0123447
Publication
First Author: Otani K
Year: 2012
Journal: Biochem Biophys Res Commun
Title: Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis.
Volume: 426
Issue: 3
Pages: 342-9
Publication
First Author: Sugita K
Year: 2007
Journal: Clin Exp Immunol
Title: Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Volume: 147
Issue: 1
Pages: 176-83
Publication
First Author: Ewaschuk JB
Year: 2007
Journal: Infect Immun
Title: Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.
Volume: 75
Issue: 5
Pages: 2572-9
Publication
First Author: Kasperkovitz PV
Year: 2011
Journal: Infect Immun
Title: Toll-like receptor 9 modulates macrophage antifungal effector function during innate recognition of Candida albicans and Saccharomyces cerevisiae.
Volume: 79
Issue: 12
Pages: 4858-67
Publication
First Author: O'Hara JR
Year: 2012
Journal: Infect Immun
Title: Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
Volume: 80
Issue: 4
Pages: 1563-71
Publication
First Author: Kim PD
Year: 2015
Journal: Infect Immun
Title: Toll-Like Receptor 9-Mediated Inflammation Triggers Alveolar Bone Loss in Experimental Murine Periodontitis.
Volume: 83
Issue: 7
Pages: 2992-3002
Publication
First Author: Naase H
Year: 2020
Journal: J Cardiothorac Surg
Title: Toll-like receptor 9 and the inflammatory response to surgical trauma and cardiopulmonary bypass.
Volume: 15
Issue: 1
Pages: 137
Publication
First Author: Takahashi K
Year: 2007
Journal: J Exp Med
Title: A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses.
Volume: 204
Issue: 12
Pages: 2963-76
Publication
First Author: Gavin AL
Year: 2018
Journal: Nat Immunol
Title: PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing.
Volume: 19
Issue: 9
Pages: 942-953
Publication
First Author: Albiger B
Year: 2007
Journal: Cell Microbiol
Title: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.
Volume: 9
Issue: 3
Pages: 633-44
Publication
First Author: Boulé MW
Year: 2004
Journal: J Exp Med
Title: Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
Volume: 199
Issue: 12
Pages: 1631-40
Publication
First Author: Henault J
Year: 2012
Journal: Immunity
Title: Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes.
Volume: 37
Issue: 6
Pages: 986-997
Publication
First Author: Mouchess ML
Year: 2011
Journal: Immunity
Title: Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation.
Volume: 35
Issue: 5
Pages: 721-32
Publication
First Author: Soni C
Year: 2020
Journal: Immunity
Title: Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA.
Volume: 52
Issue: 6
Pages: 1022-1038.e7
Publication
First Author: Morrison VL
Year: 2010
Journal: J Immunol
Title: TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection.
Volume: 185
Issue: 5
Pages: 2737-46
Publication
First Author: Busconi L
Year: 2007
Journal: J Immunol
Title: Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
Volume: 179
Issue: 11
Pages: 7397-405
Publication
First Author: Hokeness-Antonelli KL
Year: 2007
Journal: J Immunol
Title: IFN-alphabeta-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection.
Volume: 179
Issue: 9
Pages: 6176-83
Publication
First Author: Henke PK
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.
Volume: 31
Issue: 1
Pages: 43-9
Publication
First Author: Nickerson KM
Year: 2017
Journal: PLoS One
Title: Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
Volume: 12
Issue: 3
Pages: e0173471